Neuronal hyperactivity - A key defect in Alzheimer's disease?

被引:166
|
作者
Busche, Marc Aurel [1 ,2 ,3 ,4 ]
Konnerth, Arthur [1 ,3 ,4 ]
机构
[1] Tech Univ Munich, Inst Neurosci, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany
[3] Tech Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80290 Munich, Germany
[4] Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-80290 Munich, Germany
关键词
Alzheimer's disease; amyloid-ss; biomedicine; brain imaging; mouse models; neuronal dysfunction; neuronal hyperactivity; AMYLOID-BETA-PROTEIN; TRANSGENIC MOUSE MODELS; HIPPOCAMPAL ACTIVATION; PRECURSOR-PROTEIN; MEMORY DEFICITS; COGNITIVE IMPAIRMENTS; RELEASE PROBABILITY; HYPOTHETICAL MODEL; APOLIPOPROTEIN-E; UNIT-ACTIVITY;
D O I
10.1002/bies.201500004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Traditionally, the impairment of cognitive functions in Alzheimers disease (AD) is thought to result from a reduction in neuronal and synaptic activities, and ultimately cell death. Here, we review recent in vivo evidence from mouse models and human patients indicating that, particularly in early stages of AD, neuronal circuits are hyperactive instead of hypoactive. Functional analyses at many levels, from single neurons to neuronal populations to large-scale networks, with a variety of electrophysiological and imaging techniques have revealed two forms of AD-related hyperactivity and provided first insights into the synaptic mechanisms. The unexpected finding that hyperactivity is an early neuronal dysfunction represents a major conceptual shift in our understanding of AD that may have important implications for the development of therapeutic approaches.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [1] Tba Astrocyte calcium dysfunction and neuronal hyperactivity in Alzheimer's Disease
    De Strooper, B.
    Shah, D.
    GLIA, 2023, 71 : E142 - E142
  • [2] Mechanisms Underlying Neuronal "hyperactivity" in a Mouse Model of Alzheimer's Disease
    Brawek, Bianca
    Eichhoff, Gerhard
    Garaschuk, Olga
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 3A - 3A
  • [3] Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
    Bass, Britanny
    Upson, Sarah
    Roy, Kamolika
    Montgomery, Emily L.
    Jalonen, Tuula O.
    Murray, Ian V. J.
    NEURAL REGENERATION RESEARCH, 2015, 10 (07) : 1023 - 1025
  • [4] Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
    Britanny Bass
    Sarah Upson
    Kamolika Roy
    Emily L.Montgomery
    Tuula O.Jalonen
    Ian V.J.Murray
    Neural Regeneration Research, 2015, 10 (07) : 1023 - 1025
  • [5] The storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease
    Stargardt, Anita
    Swaab, Dick F.
    Bossers, Koen
    NEUROBIOLOGY OF AGING, 2015, 36 (01) : 1 - 11
  • [6] Mechanisms of Alzheimer's disease. Neuronal hyperactivity and hypoactivity as new therapeutic targets
    Busche, M. A.
    Staufenbiel, M.
    Willem, M.
    Haass, C.
    Foerstl, H.
    NERVENARZT, 2016, 87 (11): : 1163 - 1174
  • [7] Astrocytic hyperactivity in Alzheimer's disease
    Blank, N.
    Delekate, A.
    Petzold, G. C.
    GLIA, 2017, 65 : E183 - E183
  • [8] Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease
    Balmik, Abhishek Ankur
    Chinnathambi, Subashchandrabose
    CELL COMMUNICATION AND SIGNALING, 2021, 19 (01)
  • [9] Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
    Abhishek Ankur Balmik
    Subashchandrabose Chinnathambi
    Cell Communication and Signaling, 19
  • [10] A multi-scale model explains oscillatory slowing and neuronal hyperactivity in Alzheimer's disease
    Alexandersen, Christoffer G.
    de Haan, Willem
    Bick, Christian
    Goriely, Alain
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2023, 20 (198)